| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.2× | −1.8× | |
| Price / Book | 1.7× | 2.1× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −0.0× | −1.6× | |
| EV / EBITDA | −0.5× | −1.2× | |
| Earnings yield | −85.9% | −14.0% | |
| Free cash flow yield | −84,106,701.1% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLY |
| $1,273.46 |
| −2.54% |
| $1.2T |
| 59.6× |
| 77.8% |
| +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.81 | −1.42% | $635.07B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.64 | +0.16% | $504.76B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $418.09 | −1.62% | $375.28B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $145.27 | −1.34% | $358.41B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $151.12 | −3.30% | $272.31B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.49 | −0.63% | $265.96B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $673.82 | −0.40% | $249.14B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $439.26 | −1.79% | $237.48B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.04 | −0.73% | $193.48B | 22.9× | 37.5% | +26.7% |
